《外圍股市》美股期貨全面續跌0.1%-0.4% 道指期貨跌143點
Delta變種病毒於全球多國肆虐,美國、英國及日本近期疫情明顯反彈,市場重憂疫情再度反彈將阻礙全球經濟復甦動力。亞太區股市普通向下,尤其是越南跌幅擴至3.8%;港股在重磅金融及新經濟股主導下回吐479點或1.7%曾失守27,400;日經及菲股續跌1.3%及1.5%。
美股繼上周五全面跌近1%後,期貨全面續跌不足0.5%,道指期貨沽壓最大,曾再跌逾200點低見34,350,現造34,421,續跌143點或0.4%;標普五百期貨低見4,296,現造4,304,續跌14點或0.3%;納指一百期貨低見14,611,現造14,649,續跌21點或0.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.